Menu Back toSession-0802-Breakthrough-of-Innovative-Cancer-Therapies-and-Impact-on-Local-Innovation-in-China

The 7th DIA China Annual Meeting


Session 0802 Breakthrough of Innovative Cancer Therapies and Impact on Local Innovation in China

Session Chair(s)

Jian  Peng

Jian Peng

  • Sanofi R&D China, China
Xianping  LU

Xianping LU

  • CEO & Chief Scientific Officer
  • Chipscreen Biosciences, Ltd., Shenzhen, China

Clinical Progress in Innovation Treatment of Lung Cancer.pdf

Speaker(s)

Caicun  ZHOU

Caicun ZHOU

  • Director
  • Tongji University, China
Jimmy  Jin

Advanced Translational Medicines in Oncology Drug Discovery and Development

Jimmy Jin

  • TSU AsiaPacific, Sanofi R&D, China
Xianping  LU

Xianping LU

  • CEO & Chief Scientific Officer
  • Chipscreen Biosciences, Ltd., Shenzhen, China
Jason  Yang

Jason Yang

  • Senior Vice President, Clinical Development
  • BeiGene Co., Ltd, China
Zhaolong  Gong

Zhaolong Gong

  • CEO
  • 3D Medicines, China
Shunjiang  Yu

Developme Strategy& Innovative Pipeline

Shunjiang Yu

  • Director, Medical
  • Jiangsu Hengrui Medicine Co., Ltd, China, China

Contact us

For exhibition, advertising and hosting inquiry, please contact:
Jean XU: jxu@kellencompany.com, or Sofie Peeters: speeters@kellencompany.com
Tel: +86 10 5923 1096

For general inquiry, please contact DIA China office:
dia@diachina.org
Tel: +86 10 5704 2650